Literature DB >> 8439568

A retropseudogene for non-histone chromosomal protein HMG-1.

M Stros1, G H Dixon.   

Abstract

Southern analysis of the human genome revealed that there are several sequences with homology to the nonhistone chromosomal protein HMG-1. The majority of the HMG-1 sequences are intronless as suggested from the polymerase chain reaction of HeLa DNA. Sequencing of a clone from a human placenta genomic library revealed that the clone was intronless and displayed 99% homology to the human HMG-1 cDNA. The 5' regulatory motif, CCAAT, is present in the clone but there is no TATA-box. Most of the differences between the HMG-1 cDNA sequence and the clone involve point mutations with no interruption of the reading frame. The sequence is flanked at 5' and 3' ends by a 15 nucleotide long direct repeat suggesting that the clone is a processed HMG-1 retropseudogene. Sequence differences between the reading frames of the HMG-1 pseudogene and HMG-1 cDNA indicated that the pseudogene arose relatively late in evolution, approximately one million years ago. The present paper is the first study on a genomic sequence related to HMG-1 genes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8439568     DOI: 10.1016/0167-4781(93)90303-u

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Retroposed copies of the HMG genes: a window to genome dynamics.

Authors:  Liora Z Strichman-Almashanu; Michael Bustin; David Landsman
Journal:  Genome Res       Date:  2003-05       Impact factor: 9.043

2.  Cloning and characterization of the genomic DNA of the human MSSP genes.

Authors:  C Haigermoser; M Fujimoto; S M Iguchi-Ariga; H Ariga
Journal:  Nucleic Acids Res       Date:  1996-10-01       Impact factor: 16.971

3.  The HMG-1 box protein family: classification and functional relationships.

Authors:  A D Baxevanis; D Landsman
Journal:  Nucleic Acids Res       Date:  1995-05-11       Impact factor: 16.971

Review 4.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

Review 5.  High Mobility Group Box 1: a potential therapeutic target for systemic lupus erythematosus.

Authors:  Hai-Feng Pan; Guo-Cui Wu; Wei-Ping Li; Xiang-Pei Li; Dong-Qing Ye
Journal:  Mol Biol Rep       Date:  2009-02-27       Impact factor: 2.316

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.